Pathfinder Therapeutics

Pathfinder Therapeutics, Inc. (PTI) is the developer of ExplorerTM, an image-guided “GPS” device that enables physicians to accurately and efficiently guide the delivery of cancer therapeutics (usually resection and/or ablation) in soft-tissue organs. 

 

ExplorerTM is the first medical device cleared by the FDA in the category of Intraoperative Soft Tissue Tracking. ScoutTM, our advanced 3D planning software, provides highly detailed visual and volumetric information for preoperative assessment, thus enabling clinicians to visualize the site of disease, plan the resection and/or ablation and monitor the resultant effects.  Read More>



 

Unparalleled Visualization and Guidance for Abdominal Surgery
More ...
Pathfinder’s software platform and hardware system offers advanced 3D visualization and navigation
More ...
Scout Liver Surgical Planning Software Provides Highly Detailed 3D Information
More ...
Explorer Liver is indicated for open liver surgery where apneic periods can be tolerated
More ...
See Where You're Going Before You Get There
More ...

 

  News & Announcements

Pathfinder Closes $4M Series B Financing

Pathfinder Therapeutics, Inc., a pioneering company in the field of Navigated Abdominal Surgery (NAS), is pleased to announce that it has closed a $4 million Series B financing round co-led by TriStar Technology Fund, LLC and Limestone Fund, LLC. A number of existing investors also participated, including Hatteras Venture Partners, Florida Gulfshore Capital and Clayton Associates...

Read More>

Pathfinder to present at IHPBA 2010

 Pathfinder Therapeutics, Inc. is pleased to announce that it will be exhibiting at the 9th World Congress of the International Hepato-Pancreato-Biliary Association in Buenos Aires, Argentina from April 18 - 22, 2010.

Read More>

Pathfinder hires medical device veteran as CEO

 Skip Goode hired as President and CEO as Pathfinder enters commercial phase with product launch at AHPBA in Miami.

Read More>